BRD2 and metabolic syndrome: Treatment with glucocorticoids can cause hyperglycemia, insulin resistance, and dyslipidemia; prolonged use has been shown to inhibit the secretion of FSH, TSH, and LH, leading to adrenal suppression and overall adrenal insufficiency when the treatment is stopped.